150 related articles for article (PubMed ID: 31204944)
1. [Short-Term Therapeutic Efficacy, Survival Time and Side Effects in Treatment of Newly Diagnosed Multiple Myeloma Patients with Different Chemotherapeutic Regimens].
Pan PJ; Luo ZQ; Zhang ML
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):855-859. PubMed ID: 31204944
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy and safety of CTD and PCD regimens in treatment of patients with newly diagnosed multiple myeloma].
Gu Y; Yuan YH; Shi QL; Qu XY; Xu J; Guo R; Xu JD; Li JY; Chen LJ
Zhonghua Xue Ye Xue Za Zhi; 2017 Apr; 38(4):279-284. PubMed ID: 28468087
[No Abstract] [Full Text] [Related]
3. [Correlation of IgG Levels at Initial Diagnosis with Clinical Efficacy and Prognosis in 66 Patients with IgG Multiple Myeloma].
Nian FG; Li F; Shao LJ; Zhai YP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1159-1165. PubMed ID: 31418373
[TBL] [Abstract][Full Text] [Related]
4. [Influence of MRD Status in Newly Diagnosed MM Patients with VGPR and Above after Treatment on Clinical Prognosis].
Yu X; Zhang KJ; Wu XJ; Shi LJ; Lin HZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1631-1636. PubMed ID: 33067965
[TBL] [Abstract][Full Text] [Related]
5. [Influence of Combination with 1q21 Amplification or-No in Patients with Newly Diagnosed MM on the Clinical Effecacy of Bortezomib-based induction chemotherapy and Long-Term Prognosis of Patients].
Gu WW; Wang JS; Mu K; Ren G
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Aug; 28(4):1251-1255. PubMed ID: 32798407
[TBL] [Abstract][Full Text] [Related]
6. [A clinical analysis of 69 newly diagnosed multiple myeloma patients with renal insufficiency].
An N; Li X; Shen M; Chen SL; Huang ZX
Zhonghua Nei Ke Za Zhi; 2016 Oct; 55(10):764-768. PubMed ID: 27686436
[No Abstract] [Full Text] [Related]
7. [Evaluation and Comparison of Thromboelastography and Conventional Coagulation Tests for Blood Coagulation Function in Children with Henoch-Schönlein Purpura].
Xiao HF; Dong ZG; Xu WQ; Chen XY; Xin PL; Zhang JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):850-854. PubMed ID: 31204943
[TBL] [Abstract][Full Text] [Related]
8. [A cohort study comparing the efficacy and safety of bortezomib plus dexamethasone versus bortezomib, epirubicin and dexamethasone in patients with multiple myeloma].
Hao QY; Chen H; Liu KY; Wen L; Huang XJ; Lu J
Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):689-94. PubMed ID: 27586976
[TBL] [Abstract][Full Text] [Related]
9. [Clinical Features and Response to Treatment in Newly Diagnosed Multiple Myeloma Patients with Deletion 17P].
Liu Y; Ke XY; Wang J; Wang YF; Dong F; Tian L; Wan W; Jing HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):802-806. PubMed ID: 28641639
[TBL] [Abstract][Full Text] [Related]
10. Once-Weekly 1.6 mg/m
Tang Y; Yu YH; Yao YY; Zou LF; Dou HJ; Wang L; Zhu Q
Indian J Hematol Blood Transfus; 2017 Mar; 33(1):22-30. PubMed ID: 28194052
[TBL] [Abstract][Full Text] [Related]
11. [A prospective multi-center trial of non-interventional and observational study of lenalidomide in Chinese patients with multiple myeloma].
Wang GM; Yang GZ; Huang ZX; Zhong YP; Jin FY; Liao AJ; Wang XM; Fu ZZ; Liu H; Li XL; Zhou JF; Zhang X; Hu Y; Meng FY; Huang XJ; Chen WM; Lu J
Zhonghua Nei Ke Za Zhi; 2017 Jul; 56(7):500-506. PubMed ID: 28693058
[No Abstract] [Full Text] [Related]
12. [Treatment options and prognosis in newly diagnosed multiple myeloma patients].
Wang L; Tang W; Wang Y; Xu L; Zhao WL; Wu W; Chen YB; Shen ZX; Hu J
Zhonghua Xue Ye Xue Za Zhi; 2011 May; 32(5):308-12. PubMed ID: 21729598
[TBL] [Abstract][Full Text] [Related]
13. [Bortezomib-based induction therapy followed by autologous hematopoietic stem cell transplantation in multiple myeloma].
Huang B; Li J; Liu J; Gu J; Zheng D; Xu D; Zou W; Wang H
Zhonghua Nei Ke Za Zhi; 2014 Nov; 53(11):865-72. PubMed ID: 25586356
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of Curative Efficacy of Different Chemotherapy Regimen Combined with Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation on Multiple Myeloma].
Wang CB; Bai H; Xi R; Pan YZ; Wu T; Xu SF; Zhang Q; Zhou JM; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Dec; 26(6):1675-1680. PubMed ID: 30501703
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of Bortezomib for Maintenance therapy of Patients with Multiple Myeloma].
Gao LX; Jia XL; Hu J; Zhang YZ; Wu KX; Fu MW; Wang YX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Aug; 25(4):1101-1104. PubMed ID: 28823276
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy and Influencing Factors of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Retrospective Analysis].
Zhang BL; Zhou J; Zhang GL; Gui RR; Lin QD; Zu YL; Yu FC; Zhao HF; Li Z; Wang J; Fu YW; Zhang LN; Zhou H; Fang BJ; Song YP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1414-1419. PubMed ID: 30295260
[TBL] [Abstract][Full Text] [Related]
17. Long-term results in multiple myeloma after high-dose melphalan and autologous transplantation according to response categories in the era of old drugs.
Martino M; Postorino M; Gallo GA; Messina G; Neri S; Piro E; Gentile M; Moscato T; Monteleone R; Fedele R; Mazzone C; Console G; Penna G; Alati C; Vincelli ID; Irrera G; Musolino C; Ronco F; Molica S; Morabito F
Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):148-54. PubMed ID: 24417912
[TBL] [Abstract][Full Text] [Related]
18. Bortezomib, thalidomide, and dexamethasone as induction therapy for patients with symptomatic multiple myeloma: a retrospective study.
Kaufman JL; Nooka A; Vrana M; Gleason C; Heffner LT; Lonial S
Cancer; 2010 Jul; 116(13):3143-51. PubMed ID: 20564642
[TBL] [Abstract][Full Text] [Related]
19. [Clinical Efficacy and Safety of Different Doses of Dexamethasone Combined with Bortezomib and Thalidomide for Treating Patients with Multiple Myeloma].
Li CS; Ji Y; Zhang WP; Fu LP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):836-841. PubMed ID: 29950229
[TBL] [Abstract][Full Text] [Related]
20. [Bortezomib combined with other drugs for treating 60 cases of multiple myeloma].
Zhong YP; Chen SL; Li X; Hu Y; Zhang JJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):214-7. PubMed ID: 19236782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]